Midlife women’s health
Veradene publishes evidence-led health information for women 40 to 60 and is building a telehealth experience spanning perimenopause through postmenopause.
Current public focus
Veradene publishes evidence-led health information for women 40 to 60 and is building a telehealth experience spanning perimenopause through postmenopause.
Ecrina publishes evidence-led health information and a self-guided check for adults navigating excessive sweating and hyperhidrosis.
Operating model
Clinical care, where offered, runs through partnered medical groups with their own medical leadership, credentialing, and quality programs. Dispensing, where applicable, runs through qualified pharmacies. Supply relationships are evaluated for licensing, documentation, and chain-of-custody before use.
Brand operations, workflow software, and evidence governance are operated centrally so that both brands can be reviewed against the same compliance, privacy, and quality standards.
Veradene and Ecrina each operate their own public surface, supported by shared non-clinical technology, evidence governance, and partner coordination.
A shared platform model for intake, eligibility, asynchronous review, clinician messaging, and records, where those functions are offered.
A governed approach to clinical content, indication framing, decision aids, and patient-facing summaries. Health claims should be provenance-linked and reviewed before publication.
Care, where offered, is delivered through licensed medical groups with their own professional judgment, medical leadership, credentialing, and quality programs.
Dispensing, where applicable, runs through qualified pharmacies evaluated for state coverage, quality posture, sterility posture, and inspection history.
Where relevant, supply relationships are evaluated for qualification, documentation, chain-of-custody, and certificate-of-analysis review.
Quality & compliance
Medical care, where offered, is delivered by clinicians licensed in the jurisdictions where they practice, under the standards of the responsible medical group.
Dispensing, where involved, is conducted by pharmacies licensed under applicable state and federal requirements. Partners are evaluated on inspection history.
Where relevant, supply relationships are evaluated for documentation, identity testing, certificates of analysis, and chain-of-custody.
Clinical claims should be tied to appropriate evidence and reviewed before publication. Content should be versioned, with outdated guidance removed or updated deliberately.
Where PHI is created, received, maintained, or transmitted, workflows should use HIPAA-aligned safeguards and appropriate agreements among covered entities, business associates, and service providers.
Category, clinical model, and pharmacy mode are evaluated state by state. A category may operate in one state, several, or nationally.
Direct lines
Partnerships
partnerships@benchlinehealth.com
Medical groups, pharmacies, operating partners, and acquisition conversations.
Suppliers
suppliers@benchlinehealth.com
Supplier qualification, documentation, logistics, and quality-review conversations.
Operations
ops@benchlinehealth.com
Vendors, banking, insurers, and general counterparty inquiries.
Press
press@benchlinehealth.com
Press, analyst inquiries, and regulatory counsel.